Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Two Years Follow-up Results of Graspall/Graall-SA2–2008 Study: L-Asparaginase-Loaded Red Blood Cell Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL)

Blood (2012) 120 (21): 1473.

https://doi.org/10.1182/blood.V120.21.1473.1473

Published: 2012

Journal Articles

Reduced Intensity Conditioning Allogeneic Stem cell Transplantation (RIC-alloSCT) for Elderly Acute Myeloid Leukaemia (AML) Patients Over 60 Years: A “donor” Versus “no donor” Comparison

Pierre Peterlin, MD, Emmanuel Raffoux, Patrice Chevallier, MD, Thierry Guillaume, MD, Thomas Gastinne, MD, Steven Le Gouill, Philippe Moreau, MD, Hervé Dombret, MD, PhD, Mohamad Mohty, MD PhD, Jacques Delaunay, MD

Blood (2012) 120 (21): 2037.

https://doi.org/10.1182/blood.V120.21.2037.2037

Published: 2012

Journal Articles

Equivalent Outcome Between Reduced Intensity Versus Conventional Myeloablative Conditioning Hematopoietic Stem Cell Transplantation for Patients Older Than 35 Years with Acute Myeloid Leukemia.

Marie Sebert, Raphaël Porcher, Marie Robin, Lionel Ades, MD, PhD, Emmanuel Raffoux, Alienor Xhaard, Nathalie Dhedin, MD, Jerome Larghero, Chantal Himberlin, MD, Alain Delmer, MD, Pierre Fenaux, MD, PhD, Hervé Dombret, MD, PhD, Gérard Socié, MD PhD, Regis Peffault de Latour

Blood (2012) 120 (21): 3103.

https://doi.org/10.1182/blood.V120.21.3103.3103

Published: 2012

Journal Articles

Danusertib Hydrochloride (PHA-739358), a Multi-Kinase Aurora Inhibitor, Elicits Clinical Benefit in Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia .

Jorge Cortes-Franco, MD, Hervé Dombret, MD, PhD, Philippe Schafhausen, MD, Tim H Brummendorf, MD, Nicolas Boissel, MD, PhD, Fabio Latini, MD, Laura Capolongo, Bernard Laffranchi, MD, Silvia Comis, MD

Blood (2009) 114 (22): 864.

https://doi.org/10.1182/blood.V114.22.864.864

Published: 2009

Journal Articles

Identification of Specific Genes Expression Signatures for CEBPa, NPM1 and FLT3 Genes Mutations in AML. A Study Based of the MILE Data Issued from 79 French Samples.

Christophe Roumier, MD, Olivier Nibourel, MD, John Devos, PHD, Pacale Cornillet-Lefebvre, MD, Sylvia Merk, PHD, Hervé Dombret, MD-PHD, Norbert Ifrah, MD-PHD, Elisabeth Macintyre, MD-PHD, Marie-Christine Bene, MD-PHD, Jean-Pierre Kerckaert, PHD, Torsten Haferlach, MD-PHD, Claude Preudhomme, PD-PHD

Blood (2007) 110 (11): 3481.

https://doi.org/10.1182/blood.V110.11.3481.3481

Published: 2007

NARROW

Two Years Follow-up Results of Graspall/Graall-SA2–2008 Study: L-Asparaginase-Loaded Red Blood Cell Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL)

Reduced Intensity Conditioning Allogeneic Stem cell Transplantation (RIC-alloSCT) for Elderly Acute Myeloid Leukaemia (AML) Patients Over 60 Years: A “donor” Versus “no donor” Comparison

Equivalent Outcome Between Reduced Intensity Versus Conventional Myeloablative Conditioning Hematopoietic Stem Cell Transplantation for Patients Older Than 35 Years with Acute Myeloid Leukemia.

Danusertib Hydrochloride (PHA-739358), a Multi-Kinase Aurora Inhibitor, Elicits Clinical Benefit in Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia .

Identification of Specific Genes Expression Signatures for CEBPa, NPM1 and FLT3 Genes Mutations in AML. A Study Based of the MILE Data Issued from 79 French Samples.

Email alerts

ASH Publications

American Society of Hematology

Two Years Follow-up Results of Graspall/Graall-SA2–2008 Study: L-Asparaginase-Loaded Red Blood Cell Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL)

Reduced Intensity Conditioning Allogeneic Stem cell Transplantation (RIC-alloSCT) for Elderly Acute Myeloid Leukaemia (AML) Patients Over 60 Years: A “donor” Versus “no donor” Comparison

Equivalent Outcome Between Reduced Intensity Versus Conventional Myeloablative Conditioning Hematopoietic Stem Cell Transplantation for Patients Older Than 35 Years with Acute Myeloid Leukemia.

Danusertib Hydrochloride (PHA-739358), a Multi-Kinase Aurora Inhibitor, Elicits Clinical Benefit in Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia .

Identification of Specific Genes Expression Signatures for CEBPa, NPM1 and FLT3 Genes Mutations in AML. A Study Based of the MILE Data Issued from 79 French Samples.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only